Cancer vaccines.

Schiller, John T; Lowy, Douglas R; Frazer, Ian H; Finn, Olivera J; Vilar, Eduardo; Lyerly, H Kim; Gnjatic, Sacha; Zaidi, Neeha; Ott, Patrick A; Balachandran, Vinod P; Dietrich, Pierre-Yves; Migliorini, Denis; Vonderheide, Robert H; Domchek, Susan M

Cancer vaccines.

Schiller, John T; Lowy, Douglas R; Frazer, Ian H; Finn, Olivera J; Vilar, Eduardo; Lyerly, H Kim; Gnjatic, Sacha; Zaidi, Neeha; Ott, Patrick A; Balachandran, Vinod P; Dietrich, Pierre-Yves; Migliorini, Denis; Vonderheide, Robert H; Domchek, Susan M.

Cancer Cell ; 40(6): 559-564, 2022 06 13.

Article in English | MEDLINE | ID: covidwho-1944424

ABSTRACT

ABSTRACT

Given the renewed interest in vaccine development sparked by the COVID-19 pandemic, we are revisiting the current state of vaccine development for cancer prevention and treatment. Experts discuss different vaccine types, their antigens and modes of action, and where we stand on their clinical development, plus the challenges we need to overcome for their broad implementation.

Subject(s)

COVID-19; Cancer Vaccines; Neoplasms; COVID-19/prevention & control; Cancer Vaccines/therapeutic use; Humans; Neoplasms/prevention & control; Pandemics/prevention & control

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cancer Vaccines / COVID-19 / Neoplasms Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google